Saltar al contenido principal

ETHNOS_APP

Inicio • Búsqueda • Revistas • Lista 0

Efetividade da vacina antiamarílica 17D

Uma avaliação epidemiológica em serviços de saúde

Datos Bibliográficos

ID14967149
AutoresHenrique L Guerra (0000-0002-0569-0800, Fundação Oswaldo Cruz, autor de correspondencia), Tânia Mara Sardinha (Ministério da Saúde), Amélia P A Travassos Da Rosa (Instituto Evandro Chagas), Maria Fernanda Furtado Lima-Costa (0000-0002-3474-2980, Universidade Federal de Minas Gerais), Maria Fernanda Lima E Costa
Año1997
Volumen2
Número2
Páginas115-120
Fecha de publicación1997-08-01
Peer ReviewedSí
Open AccessSí
TipoARTICLE
RevistaRevista Panamericana de Salud Pública (JOURNAL)
Identificadores de la revistaISSN: 1020-4989 • E-ISSN: 1680-5348
EditorialFapUNIFESP (SciELO) (PUBLISHER)
DOI10.1590/s1020-49891997000800004
PMID9312418
OpenAlexW2061145717
SCIELO_PIDS1020-49891997000800004
IdiomaPT
Citas recibidas1
Referencias citadas5

The purpose of this study was to evaluate the efficacy of the 17D yellow fever vaccine in the conditions under which it is used in public health services. In 1989, a nonconcurrent prospective study was carried out in Bocaiúva, Minas Gerais State, Brazil, 6 months after mass vaccination of the population. The study population was made up of first-grade students from all the schools in Bocaiúva. The exposed group consisted of a simple random sample of vaccinated students (n = 173) and the unexposed group consisted of all those who had not been vaccinated (n = 55). Serum samples were examined with the neutralization test in mice; these tests were conducted blind, that is, the examiner did not know the vaccination status of the subject. The serology results were as follows: of those vaccinated, 75% were seropositive, 17% were seronegative, and 7% showed an inconclusive result; in the unvaccinated children, these results were 9%, 87%, and 4%, respectively. The age-adjusted seropositivity ratio between vaccinated and unvaccinated children was 7.6 (95% CI: 3.4 to 16.7). The proportion of seropositivity attributable to vaccination, adjusted for age, was 86.8% (95% CI: 70.6 to 94.0). The results showed that the efficacy of the vaccine, defined by means of seropositivity for the virus, was below the levels expected for the 17D vaccine. This may have been due to operational failures in the conservation or application of the vaccine. The results point to the need for routine systematic evaluations by the health services after mass utilization of the vaccine

Antibody · Environmental health · Population · Serology · Vaccination · Demography · Medicine · Mosquito-borne diseases and control · Viral Infections and Outbreaks Research · Virology and Viral Diseases · Immunology

  • Immunogenicity of WHO-17D and Brazilian 17DD yellow fever vaccines

    Open Access•Luiz Antônio Bastos Camacho, Marcos Da Silva Freire et al.•Revista de Saúde Pública•2004

  • Statistical Methods for Rates and Proportions

    Open Access•Joseph L Fleiss, Bruce Levin et al.•Statistical methods for rates and…•2003

  • Methods in observational epidemiology

    Ian Leck•Journal of Epidemiology and…•1987

  • Risco de urbanização da febre amarela no Brasil

    Open Access•José T Fiusa Lima•Cadernos de Saude Publica•1985

  • História da febre amarela no Brasil

    Open Access•Jaime Larry Benchimol•História Ciências Saúde-Manguinhos•1994

Obras citantes distintas1
Citas por año0,05
Intervalo de citas2004 - 2004 (1)
Velocidad de citaciónhistorical
Altamente citadoNo
Tipos de citaNeutras: 1
Ethnos_APP • Proyecto Open Source • Licencia MIT • Frontend v2.0.0 • Privacidad y Cookies • Documentación de la API: api.ethnos.app/docs • Código de la API: GitHub • DOI: 10.5281/zenodo.17049435 • Código del Frontend: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae